Cowen resumed coverage on Ginkgo Bioworks with a new price target
$DNA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Cowen resumed coverage of Ginkgo Bioworks with a rating of Outperform and set a new price target of $12.00